Gold Nanoclusters as an Antibacterial Alternative Against Clostridium difficile

Int J Nanomedicine. 2020 Aug 25:15:6401-6408. doi: 10.2147/IJN.S268758. eCollection 2020.

Abstract

Background: Clostridium difficile infection (CDI) has become one of the most important factors threatening human health, and about 20-30% antibiotic-related diarrhea cases and almost all pseudomembranous enteritis cases are related to CDI. The high recurrence of Clostridium difficile (C. difficile) and the emergence of drug resistance make clinical treatment of CDI difficult. Therefore, there is an urgent need to develop a non-antibiotic-alternative therapy against CDI. Gold nanoclusters (AuNCs) can better interact with bacteria due to its ultrasmall size. The aim of the present study was to explore whether AuNCs could be used as an antibacterial agent to kill C. difficile.

Methods: AuNCs and C. difficile were co-cultivated in an anaerobic atmosphere to evaluate the bactericidal effect of AuNCs. The bacterial growth rate was estimated by using two concentrations of AuNCs (50 and 100 μM). The damage of AuNCs to C. difficile is detected by SYTOX Green staining methods and SEM image analysis. The mechanism of AuNCs on C. difficile was explored by reactive oxygen species (ROS) detection. The toxic effect of AuNCs on human cells was evaluated by MTT method.

Results: AuNCs (100 μM) killed C. difficile drastically. AuNCs increased the release of ROS by about 5 fold and destroyed the membrane integrity of C. difficile cells without causing significant toxic effect on human cells.

Conclusion: AuNCs showed great potential as an alternative to traditional antibiotics in killing C. difficile and may prove to be an alternative to treat CDI.

Keywords: Clostridium difficile; antibacterial effect; gold nanoclusters; reactive oxygen species.

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology*
  • Cell Line
  • Clostridioides difficile / drug effects*
  • Clostridioides difficile / growth & development
  • Clostridioides difficile / metabolism
  • Clostridioides difficile / ultrastructure
  • Gold / chemistry
  • Gold / pharmacology*
  • Humans
  • Microbial Sensitivity Tests
  • Nanostructures / chemistry*
  • Reactive Oxygen Species / metabolism

Substances

  • Anti-Bacterial Agents
  • Reactive Oxygen Species
  • Gold

Grants and funding

This research was supported by the National Natural Science Foundation of China (81871734, 81471994); Jiangsu Provincial Natural Science Foundation (BK20151154); Jiangsu Provincial Medical Talent Project (ZDRCA2016053); Six Talent Peaks Project of Jiangsu Province (WSN-135); Advanced Health Talent of Six-one Project of Jiangsu Province (LGY2016042).